Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,290 papers from all fields of science
Search
Sign In
Create Free Account
Gabexate Methanesulfonate
Known as:
Methanesulfonate, Gabexate
, Mesylate, Gabexate
, Mesilate, Gabexate
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Foy
Broader (1)
Gabexate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
A. Andriulli
,
G. Leandro
,
+4 authors
V. Annese
Gastrointestinal Endoscopy
2007
Corpus ID: 26820096
Highly Cited
2004
Highly Cited
2004
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
A. Andriulli
,
L. Solmi
,
+13 authors
F. Perri
Clinical Gastroenterology and Hepatology
2004
Corpus ID: 45103580
Highly Cited
2004
Highly Cited
2004
Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of Gabexate Mesylate (Foy) in allergic rhinitis treatment.
G. Fundueanu
,
M. Constantin
,
+4 authors
E. Menegatti
Biomaterials
2004
Corpus ID: 21393183
Highly Cited
2001
Highly Cited
2001
Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes.
S. Aosasa
,
S. Ono
,
H. Mochizuki
,
H. Tsujimoto
,
C. Ueno
,
A. Matsumoto
Shock
2001
Corpus ID: 24937338
If the inflammatory response becomes excessive or uncontrolled by some stimuli, inappropriate inflammatory responses occur…
Expand
Highly Cited
2000
Highly Cited
2000
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
A. Andriulli
,
G. Leandro
,
+8 authors
G. De Maio
Gastrointestinal Endoscopy
2000
Corpus ID: 36774406
Highly Cited
2000
Highly Cited
2000
Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
H. Chen
,
Jih-Chang Chen
,
T. Hwang
,
Y. Jan
,
Miin-Fu Chen
Hepato-Gastroenterology
2000
Corpus ID: 29705261
BACKGROUND/AIMS Exaggerated production of various proteases may account for the late presence of organ dysfunction in acute…
Expand
Highly Cited
1996
Highly Cited
1996
Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm…
N. Kaga
,
Y. Katsuki
,
M. Obata
,
Y. Shibutani
American Journal of Obstetrics and Gynecology
1996
Corpus ID: 23917927
Highly Cited
1993
Highly Cited
1993
Gabexate mesilate in human acute pancreatitis
M. Büchler
,
P. Malfertheiner
,
+6 authors
H. Beger
1993
Corpus ID: 70401923
Highly Cited
1986
Highly Cited
1986
Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
M. Iwaki
,
Y. Ino
,
+4 authors
T. Aoyama
Japanese Journal of Pharmacology
1986
Corpus ID: 42505895
Effects of FUT-175 on the pancreatic enzymes in vitro and in vivo in the enterokinase-induced experimental acute pancreatitis…
Expand
Highly Cited
1984
Highly Cited
1984
Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.
T. Aoyama
,
Y. Ino
,
+5 authors
M. Fujita
Japanese Journal of Pharmacology
1984
Corpus ID: 25607737
FUT-175, 6-amidino-2-naphthyl p-guanidinobenzoate dimethanesulfonate (nafamstat mesilate), a novel synthetic protease-inhibiting…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required